home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Looking For Cancer In All The Right Places

  January, 9 2008 21:03
your information resource in human molecular genetics
Viable tumour-derived epithelial cells (also known as circulating tumour cells or CTCs) have been identified in the blood of cancer patients, and the hope is that these CTCs will enable physicians to characterize and monitor certain kinds of cancer in a non-invasive manner. A paper published in Nature describes the development of a unique microfluidic platform (the 'CTC-chip') that can efficiently and selectively separate CTCs from peripheral blood samples.

Mehmet Toner and colleagues have used the device to identify CTCs successfully in the peripheral blood of patients with metastatic lung, prostate, pancreas, breast and colon cancer, and they have shown that they can use the CTC-chip to monitor an individual's response to anti-cancer therapy. The approach seems to isolate more viable CTCs - and is simpler - than other methods that have been used to isolate these rare cells, so the hope is that this device could be used in clinical settings to diagnose cancer patients rapidly and monitor them while they are undergoing treatment.


Mehmet Toner (Harvard Medical School, Boston, MA, USA)
E-mail: mtoner@hms.harvard.edu

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.